Loteprednol etabonate ophthalmic suspension (short-term)
Treatment used for 1 condition
Total Trials
60
Total Participants
9K
Avg Effectiveness
75%
Avg Safety Score
65%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.